Correlation Between Bristol Myers and Enliven Therapeutics
Can any of the company-specific risk be diversified away by investing in both Bristol Myers and Enliven Therapeutics at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Bristol Myers and Enliven Therapeutics into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Bristol Myers Squibb and Enliven Therapeutics, you can compare the effects of market volatilities on Bristol Myers and Enliven Therapeutics and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Bristol Myers with a short position of Enliven Therapeutics. Check out your portfolio center. Please also check ongoing floating volatility patterns of Bristol Myers and Enliven Therapeutics.
Diversification Opportunities for Bristol Myers and Enliven Therapeutics
-0.54 | Correlation Coefficient |
Excellent diversification
The 3 months correlation between Bristol and Enliven is -0.54. Overlapping area represents the amount of risk that can be diversified away by holding Bristol Myers Squibb and Enliven Therapeutics in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Enliven Therapeutics and Bristol Myers is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Bristol Myers Squibb are associated (or correlated) with Enliven Therapeutics. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Enliven Therapeutics has no effect on the direction of Bristol Myers i.e., Bristol Myers and Enliven Therapeutics go up and down completely randomly.
Pair Corralation between Bristol Myers and Enliven Therapeutics
Considering the 90-day investment horizon Bristol Myers Squibb is expected to generate 0.32 times more return on investment than Enliven Therapeutics. However, Bristol Myers Squibb is 3.12 times less risky than Enliven Therapeutics. It trades about 0.19 of its potential returns per unit of risk. Enliven Therapeutics is currently generating about -0.09 per unit of risk. If you would invest 5,617 in Bristol Myers Squibb on November 3, 2024 and sell it today you would earn a total of 278.00 from holding Bristol Myers Squibb or generate 4.95% return on investment over 90 days.
| Time Period | 3 Months [change] |
| Direction | Moves Against |
| Strength | Very Weak |
| Accuracy | 100.0% |
| Values | Daily Returns |
Bristol Myers Squibb vs. Enliven Therapeutics
Performance |
| Timeline |
| Bristol Myers Squibb |
| Enliven Therapeutics |
Bristol Myers and Enliven Therapeutics Volatility Contrast
Predicted Return Density |
| Returns |
Pair Trading with Bristol Myers and Enliven Therapeutics
The main advantage of trading using opposite Bristol Myers and Enliven Therapeutics positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Bristol Myers position performs unexpectedly, Enliven Therapeutics can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Enliven Therapeutics will offset losses from the drop in Enliven Therapeutics' long position.| Bristol Myers vs. AbbVie Inc | Bristol Myers vs. Merck Company | Bristol Myers vs. Gilead Sciences | Bristol Myers vs. Johnson Johnson |
| Enliven Therapeutics vs. Pmv Pharmaceuticals | Enliven Therapeutics vs. Cullinan Oncology LLC | Enliven Therapeutics vs. Immuneering Corp | Enliven Therapeutics vs. Aerovate Therapeutics |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Share Portfolio module to track or share privately all of your investments from the convenience of any device.
Other Complementary Tools
| Performance Analysis Check effects of mean-variance optimization against your current asset allocation | |
| Fundamental Analysis View fundamental data based on most recent published financial statements | |
| Equity Analysis Research over 250,000 global equities including funds, stocks and ETFs to find investment opportunities | |
| Equity Forecasting Use basic forecasting models to generate price predictions and determine price momentum | |
| Portfolio Dashboard Portfolio dashboard that provides centralized access to all your investments |